Your browser doesn't support javascript.
loading
PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level.
Cao, Lianjing; Wang, Xinyue; Li, Shouying; Zhi, Qiongjie; Wang, Yuqian; Wang, Liuchun; Li, Kai; Jiang, Richeng.
Afiliación
  • Cao L; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer.
  • Wang X; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer.
  • Li S; Department of Thoracic Oncology, Tianjin Lung Cancer Center, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Tianjin 300060, PR China.
  • Zhi Q; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer.
  • Wang Y; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer.
  • Wang L; Department of Thoracic Oncology, Tianjin Lung Cancer Center, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Tianjin 300060, PR China.
  • Li K; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer.
  • Jiang R; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer.
J Cancer ; 8(16): 3251-3260, 2017.
Article en En | MEDLINE | ID: mdl-29158797
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Cancer Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Cancer Año: 2017 Tipo del documento: Article